Search research articles
Contact Us
Filters
Showing results (41-50 of 59) with videos related to
Page
of 6
Sort By:
Blood
|
September 1, 1996
Amplification of genomic DNA demonstrates the presence of the t(2;5) (p23;q35) in anaplastic large cell lymphoma, but not in other non-Hodgkin's lymphomas, Hodgkin's disease, or lymphomatoid papulosis
A H Sarris, R Luthra, V Papadimitracopoulou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 24, 2001
Primary cutaneous non-Hodgkin's lymphoma of Ann Arbor stage I: preferential cutaneous relapses but high cure rate with doxorubicin-based therapy
A H Sarris, I Braunschweig, L J Medeiros, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 1, 1997
Long-range amplification of genomic DNA detects the t(2;5)(p23;q35) in anaplastic large-cell lymphoma, but not in other non-Hodgkin's lymphomas, Hodgkin's disease, or lymphomatoid papulosis
A H Sarris, R Luthra, V Papadimitracopoulou, et al.
Leukemia & Lymphoma
|
May 30, 2001
Hodgkin's disease in patients infected with human immunodeficiency virus: frequency, presentation and clinical outcome
A M Tsimberidou, A H Sarris, L J Medeiros, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1996
Cyclosporin A does not reverse clinical resistance to paclitaxel in patients with relapsed non-Hodgkin's lymphoma
A H Sarris, A Younes, P McLaughlin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 1, 1997
Interferon-inducible protein 10 as a possible factor in the pathogenesis of cutaneous T-cell lymphomas
A H Sarris, D Daliani, R Ulmer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 9, 2000
Molecular response assessed by PCR is the most important factor predicting failure-free survival in indolent follicular lymphoma: update of the MDACC series
A López-Guillermo, F Cabanillas, P McLaughlin, et al.
Blood
|
May 16, 1998
The clinical significance of molecular response in indolent follicular lymphomas
A López-Guillermo, F Cabanillas, P McLaughlin, et al.
Leukemia & Lymphoma
|
March 28, 1998
Use of the international prognostic index and the tumor score to detect poor-risk patients with primary mediastinal large B-cell lymphoma: a study of 37 previously untreated patients
J E Romaguera, J Rodríguez Díaz-Pavon, L Carías, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 26, 2000
Liposomal vincristine in relapsed non-Hodgkin's lymphomas: early results of an ongoing phase II trial
A H Sarris, F Hagemeister, J Romaguera, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 59) with videos related to
Sort By:
Page
of 6
Blood
|
September 1, 1996
Amplification of genomic DNA demonstrates the presence of the t(2;5) (p23;q35) in anaplastic large cell lymphoma, but not in other non-Hodgkin's lymphomas, Hodgkin's disease, or lymphomatoid papulosis
A H Sarris, R Luthra, V Papadimitracopoulou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 24, 2001
Primary cutaneous non-Hodgkin's lymphoma of Ann Arbor stage I: preferential cutaneous relapses but high cure rate with doxorubicin-based therapy
A H Sarris, I Braunschweig, L J Medeiros, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 1, 1997
Long-range amplification of genomic DNA detects the t(2;5)(p23;q35) in anaplastic large-cell lymphoma, but not in other non-Hodgkin's lymphomas, Hodgkin's disease, or lymphomatoid papulosis
A H Sarris, R Luthra, V Papadimitracopoulou, et al.
Leukemia & Lymphoma
|
May 30, 2001
Hodgkin's disease in patients infected with human immunodeficiency virus: frequency, presentation and clinical outcome
A M Tsimberidou, A H Sarris, L J Medeiros, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1996
Cyclosporin A does not reverse clinical resistance to paclitaxel in patients with relapsed non-Hodgkin's lymphoma
A H Sarris, A Younes, P McLaughlin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 1, 1997
Interferon-inducible protein 10 as a possible factor in the pathogenesis of cutaneous T-cell lymphomas
A H Sarris, D Daliani, R Ulmer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 9, 2000
Molecular response assessed by PCR is the most important factor predicting failure-free survival in indolent follicular lymphoma: update of the MDACC series
A López-Guillermo, F Cabanillas, P McLaughlin, et al.
Blood
|
May 16, 1998
The clinical significance of molecular response in indolent follicular lymphomas
A López-Guillermo, F Cabanillas, P McLaughlin, et al.
Leukemia & Lymphoma
|
March 28, 1998
Use of the international prognostic index and the tumor score to detect poor-risk patients with primary mediastinal large B-cell lymphoma: a study of 37 previously untreated patients
J E Romaguera, J Rodríguez Díaz-Pavon, L Carías, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 26, 2000
Liposomal vincristine in relapsed non-Hodgkin's lymphomas: early results of an ongoing phase II trial
A H Sarris, F Hagemeister, J Romaguera, et al.
Page
of 6